The NEWTON™ Intervertebral Body Spacer System is comprised of a complete line of lumbar spinal spacers that allow anterior, posterior or lateral insertion angles to reach the intervertebral disc space. Each implant is designed with a large central window for optimum graft placement. Through the use of a minimal-exposure patent-pending tube system, the NEWTON™ devices are implanted into the intervertebral space to provide stabilization and facilitate fusion.

Read the full story here

Excaliard Pharmaceuticals, Inc. has announced positive results from its Phase 2 clinical trial of EXC 001, a new chemical entity for reducing fibrosis. Results showed that EXC 001 treatment significantly reduced scar severity in subjects undergoing an elective abdominoplasty compared to placebo. In the randomized, double-blind multicenter study conducted in the U.S., EXC 001 or placebo was administered intradermally adjacent to the surgical incision in patients who were undergoing elective abdominoplasty surgery.

Read the full story here

With an increasing number of women getting cosmetic breast surgeries done at civic hospitals in Mumbai, Parel’s KEM Hospital is holding a day-long workshop on ‘aesthetic breast surgery’ for its doctors. Experts will conduct four live breast surgeries to offer exposure to post-graduate medical students and about 70 other plastic surgeons from across the country. The four live surgeries which will be conducted as part of the workshop.

Read the full story here

A compound found in sunless tanning spray may help to heal wounds following surgery, according to new results published by plastic surgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City and biomedical engineers at Cornell University in Ithaca, N.Y., where the novel compound was developed. Results show that a sticky gel composed of polyethylene glycol and a polycarbonate of dihydroxyacetone (MPEG-pDHA) may help to seal wounds created by surgery.

Read the full story here

Detailed information on the first facial transplantation procedure performed in the United States is presented in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The patient has recovered well, with no serious complications through eight months of follow-up. With “true dedication” to her recovery, the patient has regained most facial functions, and the ability to eat solid foods and drink from a cup.

For the full story, Click Here

The American Society of Plastic Surgeons surveyed 276 of its members and found that 62 percent of them had undergone at least one cosmetic procedure. This most often included Botox injections and chemical peels. Also, a third of these doctors had undergone an actual invasive surgery, with liposuction being the most common procedure. Many of the surgeons in the survey were women.

For the full story, Click Here

TEI Biosciences Inc. has announced the introduction of its newest product line, SurgiMend® PRS for breast Reconstruction, a superior biologic mesh that featured at the ASPS Plastic Surgery 2009 conference in Seattle. TEI sells its products directly and through partnerships with some of the world’s major medical device companies. TEI’s marketed products include SurgiMend® for plastic and reconstructive surgery, breast reconstruction, muscle flap reinforcement, hernia repair, and abdominal wall reconstruction.

A survey conducted by the British Association of Aesthetic Plastic Surgeons in early 2009 indicated that two in five of their members had to undergo corrective treatments for complications caused by the injection of permanent fillers by high street clinics in the past year. The survey also showed that one in every five members of the association had to get complications with body contouring corrected.

Cytori Therapeutics has received the patent protecting its Celution® System applications for generation of adipose tissue-derived stem and regenerative cell-enhanced fat grafts that may be used in a variety of cosmetic surgery procedures, such as breast reconstruction, facial applications etc. The patent strengthens the competitive position of Celution System in the cosmetic surgery market. Cytori also seeks to protect other applications of the Celution System. Additional patents for the use of Celution System in cardiovascular and orthopedic proceduress have been filed too.

A recent study conducted by the 21st Century Oncology on radiation therapy for breast cancer has found out that the SAVI™ applicator gave very good cosmetic results without any potential side effects, for women who could not qualify for breast conservation therapy through the use of a balloon device previously available. The incidence of side effects such as seroma (fluid collection), pigmentation change, fibrosis (scar tissue) or infection in the12 recent cases was reported to be minimal. The precision of the SAVI applicator can be estimated from the fact that the maximum skin dose of radiation prescribed for patients never exceeded the amount.